medicaid glp 1 weight loss State Programs Increasingly Opting To Cover Weight-Loss Drugs Pennsylvania Medicaid Covers Newer Weight
Description
It is associated with gastrointestinal side effects including steatorrhea and rectal oily leakage and may interact with other medications thus is generally not used [169]

Future research designs should go beyond simple body composition assessments, taking muscle strength, physical performance, and quality of life as core clinical endpoints to clarify the long-term effects of GLP-1RAs on different subgroups

The product is administered via an easy-to-use prefilled pen, designed to support convenient and accurate dosing
Hypokalaemia (low potassium) can be clinically important, especially with vomiting/diarrhoea or low intake

There is a randomized controlled phase 2 study with the objective to explore the use of TZP as a treatment for MAFLD, providing strong evidence [NCT04166773]
